Global Viral Vector Development Service Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Development Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Retroviral Vectors
1.2.3 Lentiviral Vectors
1.2.4 Adenoviral Vectors
1.2.5 Adeno-associated Viral Vectors
1.2.6 Others Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vector Development Service Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Manufacturers
1.3.3 Biotechnology Companies
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Viral Vector Development Service Market Size (2017-2028)
2.2 Viral Vector Development Service Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Viral Vector Development Service Market Size by Region (2017-2022)
2.4 Global Viral Vector Development Service Market Size Forecast by Region (2023-2028)
2.5 Global Top Viral Vector Development Service Countries Ranking by Market Size
3 Viral Vector Development Service Competitive by Company
3.1 Global Viral Vector Development Service Revenue by Players
3.1.1 Global Viral Vector Development Service Revenue by Players (2017-2022)
3.1.2 Global Viral Vector Development Service Market Share by Players (2017-2022)
3.2 Global Viral Vector Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Viral Vector Development Service Revenue
3.4 Global Viral Vector Development Service Market Concentration Ratio
3.4.1 Global Viral Vector Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Development Service Revenue in 2021
3.5 Global Viral Vector Development Service Key Players Head office and Area Served
3.6 Key Players Viral Vector Development Service Product Solution and Service
3.7 Date of Enter into Viral Vector Development Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Viral Vector Development Service Breakdown Data by Type
4.1 Global Viral Vector Development Service Historic Revenue by Type (2017-2022)
4.2 Global Viral Vector Development Service Forecasted Revenue by Type (2023-2028)
5 Global Viral Vector Development Service Breakdown Data by Application
5.1 Global Viral Vector Development Service Historic Market Size by Application (2017-2022)
5.2 Global Viral Vector Development Service Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Viral Vector Development Service Revenue by Company (2020-2022)
6.2 North America Viral Vector Development Service Revenue by Type (2017-2028)
6.3 North America Viral Vector Development Service Revenue by Application (2017-2028)
6.4 North America Viral Vector Development Service Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Viral Vector Development Service Revenue by Company (2020-2022)
7.2 Europe Viral Vector Development Service Revenue by Type (2017-2028)
7.3 Europe Viral Vector Development Service Revenue by Application (2017-2028)
7.4 Europe Viral Vector Development Service Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Viral Vector Development Service Revenue by Company (2020-2022)
8.2 Asia Pacific Viral Vector Development Service Revenue by Type (2017-2028)
8.3 Asia Pacific Viral Vector Development Service Revenue by Application (2017-2028)
8.4 Asia Pacific Viral Vector Development Service Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Viral Vector Development Service Revenue by Company (2020-2022)
9.2 Latin America Viral Vector Development Service Revenue by Type (2017-2028)
9.3 Latin America Viral Vector Development Service Revenue by Application (2017-2028)
9.4 Latin America Viral Vector Development Service Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Viral Vector Development Service Revenue by Company (2020-2022)
10.2 Middle East and Africa Viral Vector Development Service Revenue by Type (2017-2028)
10.3 Middle East and Africa Viral Vector Development Service Revenue by Application (2017-2028)
10.4 Middle East and Africa Viral Vector Development Service Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 UJIFILM Diosynth Biotechnologies
11.1.1 UJIFILM Diosynth Biotechnologies Company Details
11.1.2 UJIFILM Diosynth Biotechnologies Business Overview
11.1.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Products and Services
11.1.4 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022)
11.1.5 UJIFILM Diosynth Biotechnologies Viral Vector Development Service SWOT Analysis
11.1.6 UJIFILM Diosynth Biotechnologies Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Viral Vector Development Service Products and Services
11.2.4 Sanofi Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022)
11.2.5 Sanofi Viral Vector Development Service SWOT Analysis
11.2.6 Sanofi Recent Developments
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Viral Vector Development Service Products and Services
11.3.4 Spark Therapeutics Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022)
11.3.5 Spark Therapeutics Viral Vector Development Service SWOT Analysis
11.3.6 Spark Therapeutics Recent Developments
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vector Development Service Products and Services
11.4.4 UniQure Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022)
11.4.5 UniQure Viral Vector Development Service SWOT Analysis
11.4.6 UniQure Recent Developments
11.5 MassBiologics
11.5.1 MassBiologics Company Details
11.5.2 MassBiologics Business Overview
11.5.3 MassBiologics Viral Vector Development Service Products and Services
11.5.4 MassBiologics Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022)
11.5.5 MassBiologics Viral Vector Development Service SWOT Analysis
11.5.6 MassBiologics Recent Developments
11.6 FinVector
11.6.1 FinVector Company Details
11.6.2 FinVector Business Overview
11.6.3 FinVector Viral Vector Development Service Products and Services
11.6.4 FinVector Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022)
11.6.5 FinVector Viral Vector Development Service SWOT Analysis
11.6.6 FinVector Recent Developments
11.7 Thermo Fisher Scientific (Brammer Bio)
11.7.1 Thermo Fisher Scientific (Brammer Bio) Company Details
11.7.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.7.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Products and Services
11.7.4 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022)
11.7.5 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service SWOT Analysis
11.7.6 Thermo Fisher Scientific (Brammer Bio) Recent Developments
11.8 Cell and Gene Therapy Catapult
11.8.1 Cell and Gene Therapy Catapult Company Details
11.8.2 Cell and Gene Therapy Catapult Business Overview
11.8.3 Cell and Gene Therapy Catapult Viral Vector Development Service Products and Services
11.8.4 Cell and Gene Therapy Catapult Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022)
11.8.5 Cell and Gene Therapy Catapult Viral Vector Development Service SWOT Analysis
11.8.6 Cell and Gene Therapy Catapult Recent Developments
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Details
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Viral Vector Development Service Products and Services
11.9.4 Cobra Biologics Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022)
11.9.5 Cobra Biologics Viral Vector Development Service SWOT Analysis
11.9.6 Cobra Biologics Recent Developments
12 Viral Vector Development Service Market Dynamics
12.1 Viral Vector Development Service Market Trends
12.2 Viral Vector Development Service Market Drivers
12.3 Viral Vector Development Service Market Challenges
12.4 Viral Vector Development Service Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Viral Vector Development Service Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Retroviral Vectors
Table 3. Key Players of Lentiviral Vectors
Table 4. Key Players of Adenoviral Vectors
Table 5. Key Players of Adeno-associated Viral Vectors
Table 6. Key Players of Others Viral Vectors
Table 7. Global Viral Vector Development Service Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Viral Vector Development Service Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Viral Vector Development Service Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Viral Vector Development Service Revenue Market Share by Region (2017-2022)
Table 11. Global Viral Vector Development Service Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Viral Vector Development Service Market Share by Players (2017-2022)
Table 13. Global Top Viral Vector Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Development Service as of 2021)
Table 14. Ranking of Global Top Viral Vector Development Service Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Viral Vector Development Service Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Viral Vector Development Service Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Viral Vector Development Service Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Viral Vector Development Service Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Viral Vector Development Service Revenue Market Share by Type (2017-2022)
Table 22. Global Viral Vector Development Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Viral Vector Development Service Revenue Market Share by Type (2023-2028)
Table 24. Global Viral Vector Development Service Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global Viral Vector Development Service Revenue Market Share by Application (2017-2022)
Table 26. Global Viral Vector Development Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global Viral Vector Development Service Revenue Market Share by Application (2023-2028)
Table 28. North America Viral Vector Development Service Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Viral Vector Development Service Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Viral Vector Development Service Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Viral Vector Development Service Revenue by Application (2017-2022) & (US$ Million)
Table 32. North America Viral Vector Development Service Revenue by Application (2023-2028) & (US$ Million)
Table 33. North America Viral Vector Development Service Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Viral Vector Development Service Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Viral Vector Development Service Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Viral Vector Development Service Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Viral Vector Development Service Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Viral Vector Development Service Revenue by Application (2017-2022) & (US$ Million)
Table 39. Europe Viral Vector Development Service Revenue by Application (2023-2028) & (US$ Million)
Table 40. Europe Viral Vector Development Service Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Viral Vector Development Service Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Viral Vector Development Service Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Viral Vector Development Service Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Viral Vector Development Service Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Viral Vector Development Service Revenue by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Viral Vector Development Service Revenue by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Viral Vector Development Service Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Viral Vector Development Service Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Viral Vector Development Service Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Viral Vector Development Service Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Viral Vector Development Service Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Viral Vector Development Service Revenue by Application (2017-2022) & (US$ Million)
Table 53. Latin America Viral Vector Development Service Revenue by Application (2023-2028) & (US$ Million)
Table 54. Latin America Viral Vector Development Service Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Viral Vector Development Service Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Viral Vector Development Service Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Viral Vector Development Service Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Viral Vector Development Service Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Viral Vector Development Service Revenue by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Viral Vector Development Service Revenue by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Viral Vector Development Service Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Viral Vector Development Service Revenue by Country (2023-2028) & (US$ Million)
Table 63. UJIFILM Diosynth Biotechnologies Company Details
Table 64. UJIFILM Diosynth Biotechnologies Business Overview
Table 65. UJIFILM Diosynth Biotechnologies Viral Vector Development Service Product and Services
Table 66. UJIFILM Diosynth Biotechnologies Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022) & (US$ Million)
Table 67. UJIFILM Diosynth Biotechnologies Viral Vector Development Service SWOT Analysis
Table 68. UJIFILM Diosynth Biotechnologies Recent Developments
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Viral Vector Development Service Product and Services
Table 72. Sanofi Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022) & (US$ Million)
Table 73. Sanofi Viral Vector Development Service SWOT Analysis
Table 74. Sanofi Recent Developments
Table 75. Spark Therapeutics Company Details
Table 76. Spark Therapeutics Business Overview
Table 77. Spark Therapeutics Viral Vector Development Service Product and Services
Table 78. Spark Therapeutics Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022) & (US$ Million)
Table 79. Spark Therapeutics Viral Vector Development Service SWOT Analysis
Table 80. Spark Therapeutics Recent Developments
Table 81. UniQure Company Details
Table 82. UniQure Business Overview
Table 83. UniQure Viral Vector Development Service Product and Services
Table 84. UniQure Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022) & (US$ Million)
Table 85. UniQure Viral Vector Development Service SWOT Analysis
Table 86. UniQure Recent Developments
Table 87. MassBiologics Company Details
Table 88. MassBiologics Business Overview
Table 89. MassBiologics Viral Vector Development Service Product and Services
Table 90. MassBiologics Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022) & (US$ Million)
Table 91. MassBiologics Viral Vector Development Service SWOT Analysis
Table 92. MassBiologics Recent Developments
Table 93. FinVector Company Details
Table 94. FinVector Business Overview
Table 95. FinVector Viral Vector Development Service Product and Services
Table 96. FinVector Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022) & (US$ Million)
Table 97. FinVector Viral Vector Development Service SWOT Analysis
Table 98. FinVector Recent Developments
Table 99. Thermo Fisher Scientific (Brammer Bio) Company Details
Table 100. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 101. Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Product and Services
Table 102. Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022) & (US$ Million)
Table 103. Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service SWOT Analysis
Table 104. Thermo Fisher Scientific (Brammer Bio) Recent Developments
Table 105. Cell and Gene Therapy Catapult Company Details
Table 106. Cell and Gene Therapy Catapult Business Overview
Table 107. Cell and Gene Therapy Catapult Viral Vector Development Service Product and Services
Table 108. Cell and Gene Therapy Catapult Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022) & (US$ Million)
Table 109. Cell and Gene Therapy Catapult Viral Vector Development Service SWOT Analysis
Table 110. Cell and Gene Therapy Catapult Recent Developments
Table 111. Cobra Biologics Company Details
Table 112. Cobra Biologics Business Overview
Table 113. Cobra Biologics Viral Vector Development Service Product and Services
Table 114. Cobra Biologics Viral Vector Development Service Revenue in Viral Vector Development Service Business (2017-2022) & (US$ Million)
Table 115. Cobra Biologics Viral Vector Development Service SWOT Analysis
Table 116. Cobra Biologics Recent Developments
Table 117. Viral Vector Development Service Market Trends
Table 118. Viral Vector Development Service Market Drivers
Table 119. Viral Vector Development Service Market Challenges
Table 120. Viral Vector Development Service Market Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Viral Vector Development Service Sales Market Share by Type: 2021 VS 2028
Figure 2. Retroviral Vectors Features
Figure 3. Lentiviral Vectors Features
Figure 4. Adenoviral Vectors Features
Figure 5. Adeno-associated Viral Vectors Features
Figure 6. Others Viral Vectors Features
Figure 7. Global Viral Vector Development Service Sales Market Share by Application: 2021 VS 2028
Figure 8. Pharmaceutical Manufacturers Case Studies
Figure 9. Biotechnology Companies Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Viral Vector Development Service Report Years Considered
Figure 12. Global Viral Vector Development Service Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Viral Vector Development Service Market Size 2017-2028 (US$ Million)
Figure 14. Global Viral Vector Development Service Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Viral Vector Development Service Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Viral Vector Development Service Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Viral Vector Development Service Market Share by Players in 2021
Figure 18. Global Top Viral Vector Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Development Service as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Viral Vector Development Service Revenue in 2021
Figure 20. North America Viral Vector Development Service Revenue Market Share by Company in 2021
Figure 21. North America Viral Vector Development Service Revenue Market Share by Type (2017-2028)
Figure 22. North America Viral Vector Development Service Revenue Market Share by Application (2017-2028)
Figure 23. North America Viral Vector Development Service Revenue Share by Country (2017-2028)
Figure 24. U.S. Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Viral Vector Development Service Revenue Market Share by Company in 2021
Figure 27. Europe Viral Vector Development Service Revenue Market Share by Type (2017-2028)
Figure 28. Europe Viral Vector Development Service Revenue Market Share by Application (2017-2028)
Figure 29. Europe Viral Vector Development Service Revenue Share by Country (2017-2028)
Figure 30. Germany Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 31. France Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Viral Vector Development Service Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Viral Vector Development Service Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Viral Vector Development Service Revenue Market Share by Application (2017-2028)
Figure 38. Asia Pacific Viral Vector Development Service Revenue Share by Region (2017-2028)
Figure 39. China Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 42. India Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 44. Taiwan Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 48. Philippines Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 49. Vietnam Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 50. Latin America Viral Vector Development Service Revenue Market Share by Company in 2021
Figure 51. Latin America Viral Vector Development Service Revenue Market Share by Type (2017-2028)
Figure 52. Latin America Viral Vector Development Service Revenue Market Share by Application (2017-2028)
Figure 53. Latin America Viral Vector Development Service Revenue Share by Country (2017-2028)
Figure 54. Mexico Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 55. Brazil Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 56. Argentina Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 57. Middle East and Africa Viral Vector Development Service Revenue Market Share by Company in 2021
Figure 58. Middle East and Africa Viral Vector Development Service Revenue Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Viral Vector Development Service Revenue Market Share by Application (2017-2028)
Figure 60. Middle East and Africa Viral Vector Development Service Revenue Share by Country (2017-2028)
Figure 61. Turkey Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 62. Saudi Arabia Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 63. U.A.E Viral Vector Development Service Revenue (2017-2028) & (US$ Million)
Figure 64. UJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Development Service Business (2017-2022)
Figure 65. Sanofi Revenue Growth Rate in Viral Vector Development Service Business (2017-2022)
Figure 66. Spark Therapeutics Revenue Growth Rate in Viral Vector Development Service Business (2017-2022)
Figure 67. UniQure Revenue Growth Rate in Viral Vector Development Service Business (2017-2022)
Figure 68. MassBiologics Revenue Growth Rate in Viral Vector Development Service Business (2017-2022)
Figure 69. FinVector Revenue Growth Rate in Viral Vector Development Service Business (2017-2022)
Figure 70. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vector Development Service Business (2017-2022)
Figure 71. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector Development Service Business (2017-2022)
Figure 72. Cobra Biologics Revenue Growth Rate in Viral Vector Development Service Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed